BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 12002116)

  • 1. Hodgkin's disease after treatment for Burkitt's lymphoma: case report.
    Kotila TR; Aken'ova YA; Shokunbi WA; Akingbola TS; Fasola FA
    East Afr Med J; 2001 Jun; 78(6):334-6. PubMed ID: 12002116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The malignant lymphomas of Kenya: morphology, immunophenotype, and frequency of Epstein-Barr virus in 73 cases.
    Cool CD; Bitter MA
    Hum Pathol; 1997 Sep; 28(9):1026-33. PubMed ID: 9308726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burkitt's lymphoma-leukemia in patients treated for Hodgkin's disease.
    Salloum E; Tallini G; Levy A; Cooper DL
    Cancer Invest; 1996; 14(6):527-33. PubMed ID: 8951357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A therapeutic approach in Burkitt's lymphoma. 2 case reports from the Hospital Central da Beira/Mozambique].
    Schneidewind A
    Fortschr Med Orig; 2001; 119(1):5-8. PubMed ID: 11935660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant lymphoma in western Ethiopia.
    Getachew A
    East Afr Med J; 2001 Aug; 78(8):402-4. PubMed ID: 11921560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal identification of Burkitt's lymphoma arising from lymphocyte-predominant Hodgkin's disease.
    Yoshinaga H; Ohashi K; Yamamoto K; Miki T; Miura O; Saito T; Koyama T; Kanazawa A; Nemoto T; Miyasaka N; Kamiyama R; Hirosawa S
    Br J Haematol; 1996 Nov; 95(2):380-2. PubMed ID: 8904897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intensive chemotherapy in Burkitt's lymphoma and aggressive non-Hodgkin's lymphoma].
    Holte H; Smeland S; Blystad AK; Kvaløy S; Hammerstrøm J; Tjønnfjord GE
    Tidsskr Nor Laegeforen; 2002 Feb; 122(4):364-9. PubMed ID: 11915663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphomas in University College Hospital, Ibadan, Nigeria.
    Okpala IE; Akang EE; Okpala UJ
    Cancer; 1991 Sep; 68(6):1356-60. PubMed ID: 1873787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Undifferentiated non-Hodgkin's lymphomas (Burkitt's and non-Burkitt's types). The relevance of making this histologic distinction.
    Miliauskas JR; Berard CW; Young RC; Garvin AJ; Edwards BK; DeVita VT
    Cancer; 1982 Nov; 50(10):2115-21. PubMed ID: 7127252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of lymphoma.
    Sullivan MP
    Cancer; 1975 Mar; 35(3 suppl):991-5. PubMed ID: 1089476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathology of non-Hodgkin's lymphoma of childhood: II. Reproducibility and relevance of the histologic classification of "undifferentiated" lymphomas (Burkitt's versus non-Burkitt's).
    Wilson JF; Kjeldsberg CR; Sposto R; Jenkin RD; Chilcote RR; Coccia P; Exelby RR; Kersey J; Meadows A; Siegel S
    Hum Pathol; 1987 Oct; 18(10):1008-14. PubMed ID: 3653876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bilateral non-Hodgkin's lymphoma of the kidneys as the only manifestation].
    Hönecke KM; Strohmenger P; Hegge T
    Urologe A; 1996 Jan; 35(1):51-3. PubMed ID: 8851849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prolonged remission of Burkitt's lymphoma stage IV secondary to Hodgkin's disease].
    Cahn JY; Flesch M; Rozenbaum A; Tiberghien P; Lenys R; Carbillet JP; Bosset JF; Leconte des Floris R
    Presse Med; 1988 Feb; 17(4):167. PubMed ID: 2964617
    [No Abstract]   [Full Text] [Related]  

  • 14. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma.
    Kamel OW; Gelb AB; Shibuya RB; Warnke RA
    Am J Pathol; 1993 Feb; 142(2):541-6. PubMed ID: 7679553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhabdomyosarcoma masquerading as lymphadenopathy in a patient with newly diagnosed Hodgkin's lymphoma.
    Dergan J; Sirsi S; Asarian A; Guevara E; Xiao P
    World J Surg Oncol; 2016 Apr; 14():101. PubMed ID: 27038637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to overcome myelotoxic therapy for the treatment of Burkitt's and AIDS-related non-Hodgkin's lymphoma.
    Rochford R; Feuer G; Orem J; Banura C; Katongole-Mbidde E; Mwanda WO; Moormann A; Harrington WJ; Remick SC
    East Afr Med J; 2005 Sep; 82(9 Suppl):S155-60. PubMed ID: 16619692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of malignant lymphomas in Rwanda.
    Ngendahayo P; Schmauz R
    Bull Cancer; 1992; 79(11):1087-96. PubMed ID: 1302535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Burkitt lymphoma].
    Santoro G; Rocco P
    G Chir; 1996; 17(8-9):405-7. PubMed ID: 9004834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary ovarian Burkitt's lymphoma: a rare oncological problem in gynaecology: a review of literature.
    Stepniak A; Czuczwar P; Szkodziak P; Wozniakowska E; Wozniak S; Paszkowski T
    Arch Gynecol Obstet; 2017 Oct; 296(4):653-660. PubMed ID: 28770352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric lymphoma diagnosis: role of FNAC, biopsy, immunohistochemistry and molecular diagnostics.
    Iyer VK
    Indian J Pediatr; 2013 Sep; 80(9):756-63. PubMed ID: 23925793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.